Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Jul 18, 2016; 8(20): 844-849
Published online Jul 18, 2016. doi: 10.4254/wjh.v8.i20.844
Table 1 The characteristics of patients with Grades II and III hemorrhoids
Goligher classificationGrade IIGrade IIIStatistical significance
Number169435
Gender
Male103231NS
Female66204
Age (yr)58 ± 1859 ± 16NS
Injection dose of ALTA (mL)13.4 ± 5.221.5 ± 6.8P < 0.0001
Operative time14 ± 816 ± 7P = 0.0020
Table 2 Prognostic factors associated with the recurrence of hemorrhoids after aluminum potassium sulfate and tannic acid sclerotherapy
Prognostic factorRelative risk (95%CI)P value
Age0.997 (0.981-1.012)0.6567
Gender0.800 (0.469-1.365)0.4124
Goligher grade1.768 (0.897-3.483)0.0997
Operation time0.974 (0.941-1.010)0.1542
ALTA injection dose0.976 (0.941-1.012)0.1901
Complication1.293 (0.469-3.564)0.6189
Table 3 Scheme of recurrence rate and/or additional operation rate of each hemorrhoid treatment
Ref.GradeTechniquenFollow-upRecurrence rate and/or additional surgery rate (%)
Giordano et al[4]II, IIITHD283 yr14.00
SH2413.00
Giordano et al[17]IVTHD + targeted mucopexy3132 mo6.40
Ratto et al[18]II, III, IVTHD17011.5 mo4.10
Ratto et al[19]II, III, IVTHD80311.1 mo10.20
Zampieri et al[20]III, IVTHD461-6 mo0
Ligasure684.00
Theodoropoulos et al[21]III, IVDGHAL + RAR14715 mo4.00
Walega et al[22]III, IVDGHAL + RAR293 mo10.34
Gravié et al[23]SH632 yr7.50
MMH631.80
Ammaturo et al[24]IIISH392 yr13.00
MMH400
Hachiro et al[8]III, IVALTA44829 mo3.60
Takano et al[6]III, IVALTA (OC-108)801 yr16.00
CH852.00
Miyamoto et al[7]II, III, IVALTA285 mo10.70